{"abstract": "Questions about Zilmax, a feed additive made by Merck, show the market dangers of an increasingly complicated global food chain, Kevin Allison of Reuters Breakingviews writes.", "web_url": "https://dealbook.nytimes.com/2013/12/31/the-risks-of-investing-in-animal-medicine/", "snippet": "Questions about Zilmax, a feed additive made by Merck, show the market dangers of an increasingly complicated global food chain, Kevin Allison of Reuters Breakingviews writes.", "lead_paragraph": "Animal medicine, whether for livestock or pets, is a booming business. Pfizer\u2019s recent spinoff, Zoetis, trades at a large valuation premium to traditional drug makers, for example.", "source": "The New York Times", "multimedia": [], "headline": {"main": "The Risks of Investing in Animal Medicine", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Cargill Inc", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Tyson Foods Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Zoetis Inc", "rank": 5, "major": "N"}], "pub_date": "2013-12-31T17:00:27+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Kevin Allison", "person": [{"firstname": "Kevin", "middlename": null, "lastname": "Allison", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/97a577bf-5552-53fc-bdd3-c10bb8e3e0a4", "word_count": 403, "uri": "nyt://article/97a577bf-5552-53fc-bdd3-c10bb8e3e0a4"}